Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
- PMID: 28206828
- PMCID: PMC5405807
- DOI: 10.1177/1352458517690823
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
Abstract
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with multiple sclerosis (MS). One of the MSOAC goals is acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful in MS. This article addresses the history, application, and psychometric properties of one such MSOAC metric of ambulation or walking namely, the timed 25-foot walk (T25FW). The T25FW has strong reliability over both brief and long periods of time in MS across a large range of disability levels. The outcome of walking speed from the T25FW has obvious real-world relevance and has correlated strongly with other measures of walking and lower extremity function. The T25FW is responsive for capturing intervention effects in pharmacological and rehabilitation trials and has an established value for capturing clinically meaningful change in ambulation. Directions for future research involve validating clinically meaningful improvements on the T25FW as well as determining whether 20% change is clinically meaningful across the disability spectrum. Researchers might further consider synchronizing accelerometers and motion sensors with the T25FW for capturing walking speed in everyday life and the patient's real environment.
Keywords: Ambulation; gait; multiple sclerosis; reliability; validity; walking.
Conflict of interest statement
Figures
Comment in
-
The measure tells the tale: Clinical outcome measures in multiple sclerosis.Mult Scler. 2017 Apr;23(5):626-627. doi: 10.1177/1352458517690825. Epub 2017 Feb 16. Mult Scler. 2017. PMID: 28206813 No abstract available.
References
-
- Murray TJ. Multiple sclerosis: The history of a disease. New York: Demos, 2005.
-
- Hessen C, Bohm J, Reich C, et al. Patient perception of bodily functions in multiple sclerosis: Gait and visual function are the most valuable. Mult Scler 2008; 14: 988–991. - PubMed
-
- LaRocca NG. Impact of walking impairment in multiple sclerosis: Perspectives of patients and care partners. Patient 2011; 4: 189–201. - PubMed
-
- Motl RW. Ambulation and multiple sclerosis. Phys Med Rehabil Clin N Am 2013; 24: 325–336. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
